Stepan Melnyk

OverviewAI-generated summary

Stepan Melnyk's research focuses on the intersection of environmental exposures, metabolic health, and neurodevelopmental outcomes, particularly in early childhood. His work investigates the impact of oxidative stress and epigenetic alterations on conditions such as Autism Spectrum Disorder (ASD) and childhood obesity. Melnyk has explored the use of sulforaphane as a potential intervention for ASD in children and has examined associations between prenatal biomarkers of oxidative stress, like isoprostanes, and neurodevelopmental trajectories.

His investigations extend to metabolic profiling in animal models, analyzing serum metabolomics in Zucker rats to understand redox imbalance and methylation disturbances in obesity. Melnyk also contributes to research on the mechanisms of cancer, specifically studying how enhancer-activated RET confers protection against oxidative stress in certain types of acute myeloid leukemia. His publication record includes studies on intestinal permeability in rodent models of radiation injury, highlighting a breadth of research interests within biological and medical sciences.

With a substantial publication record (175 publications, 10,779 citations) and an h-index of 54, Melnyk is recognized as a highly cited researcher. He collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Igor Koturbash, Reza Hakkak, Martin Hauer‐Jensen, and Rupak Pathak, with whom he shares multiple publications.

Metrics

• h-index: 54
• Publications: 175
• Citations: 10,779